Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: Final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study

Michele Baccarani, Brian J. Druker, Susan Branford, Dong Wook Kim, Fabrizio Pane, Lidia Mongay, Manisha Mone, Christine Elke Ortmann, Hagop M. Kantarjian, Jerald P. Radich, Timothy P. Hughes, Jorge E. Cortes, François Guilhot

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: Final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study'. Together they form a unique fingerprint.

Medicine & Life Sciences